RALEIGH, January 24, 2024, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Vicki Gashwiler as Vice President of Clinical Operations for their Medical Technology organization.
A proven leader in global clinical operations, Vicki has excelled in a range of roles at both innovator companies and CROs with responsibilities that have spanned the activities required to successfully execute clinical trials in the MedTech space. Vicki brings her strong leadership skills, nursing and healthcare background and her impressive track record of planning and successfully delivering clinical trials to quickly advance products through the clinical lifecycle. Prior to joining ProPharma, the world's largest RCO (Research Consulting Organization), Vicki held leadership roles in clinical operations at Abbott Vascular, ICON, SpineThera and Premier Research.
Throughout her career, Vicki has demonstrated exemplary leadership to achieve corporate, operational, and financial goals while always focusing on exceeding client expectations. Her education and experiences as a Registered Nurse drive her patient centric focus in executing all clinical trials. Vicki’s collaborative approach in developing and executing clinical strategies, domestically and internationally, has enabled the cultivation of an effective, productive, and efficient atmosphere that is conducive to long-term and future-focused organizational growth that delivers maximum value for the client.
Michael Stomberg, ProPharma’s Chief Executive Officer, said: “We are excited to welcome Vicki to the team. Her extensive MedTech experience across the device and diagnostic industry makes her an ideal match for this vital role. Vicki’s demonstrated operational and commercial leadership bolsters ProPharma’s commitment to improving the health and safety of patients.”
Ronald Freeze, ProPharma’s Global Head of Medical Technology, said: “I am so excited to have Vicki joining our integrated MedTech team. Her proven leadership and her breadth and depth of experience in planning and executing clinical trials will immediately add value for our clients and our internal team. This is another leap forward as we continue to scale our MedTech RCO to keep up with market demand.”
ProPharma again shows their commitment to the Medical Technology space and the ongoing advancement of its revolutionary Research Consulting Organization (RCO) model with Vicki’s appointment as the Vice President of Clinical Operations for Medical Technology. This strategic move ensures robust leadership and positions the organization to surpass its operational and financial targets through the design and delivery of MedTech clinical trials around the world.
About ProPharma
For the past 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.
For more information about ProPharma, please visit: https://www.propharmagroup.com.
###
Media Contacts
Zosya Popik
Vice President, Global Marketing
ProPharma
zosya.popik@propharmagroup.com
